Back to Search Start Over

Vision loss and 12-year risk of dementia in older adults: the 3C cohort study

Authors :
Naël, Virginie
Pérès, Karine
Dartigues, Jean-François
Letenneur, Luc
Amieva, Hélène
Arleo, Angelo
Scherlen, Anne-Catherine
Tzourio, Christophe
Berr, Claudine
Carrière, Isabelle
Helmer, Catherine
Sense-Cog consortium
Constantinidou, Fofi
Delcourt, Cécile
Constantinidou, Fofi [0000-0002-7928-8363]
Bordeaux population health (BPH)
Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Sorbonne Université (SU)
Institut de la Vision
Centre National de la Recherche Scientifique (CNRS)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Essilor International
CMRR - Centres Mémoire de Ressources et de Recherche [CHU Bordeaux]
CHU Bordeaux [Bordeaux]
Neuropsychiatrie : recherche épidémiologique et clinique (PSNREC)
Université Montpellier 1 (UM1)-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)
The Three-City study is conducted under a partnership agreement between the Institut National de la Santé et de la Recherche Médicale (INSERM), the University Bordeaux 2 Victor Segalen and Sanofi-Aventis. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The Three-City study is also supported by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Conseils Régionaux d’Aquitaine et Bourgogne, Fondation de France, Ministry of Research-INSERM Programme 'Cohortes et collections de données biologiques', Agence Nationale de la Recherche ANR PNRA 2006 and LongVie 2007, the 'Fondation Plan Alzheimer' (FCS 2009-2012) and the Caisse Nationale de Solidarité pour l’Autonomie (CNSA). None of the sponsors participated in the collection, management, statistical analysis and interpretation of the data, nor in the preparation, review or approval of the present manuscript. SENSE-Cog has received funding from the European Union’s Horizon 2020 research and innovation program under Grant agreement No. 668648.
Sense-Cog consortium : Bertelsen G, Cosh S, Cougnard-Grégoire A, Dawes P, Delcourt C, Constantinidou F, Helmer C, Arfan Ikram M, Klaver CCW, Leroi I, Maharani A, Meester-Smor M, Mutlu U, Nael V, Pendleton N, Schirmer H, Tampubolon G, Tiemeier H, von Hanno T.
European Project: 668648,H2020,H2020-PHC-2015-two-stage,SENSE-Cog(2016)
Delcourt, Cécile
Ears, Eyes and Mind: The ‘SENSE-Cog Project’ to improve mental well-being for elderly Europeans with sensory impairment - SENSE-Cog - - H20202016-01-01 - 2020-12-31 - 668648 - VALID
Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
Epidemiology
Neurology
Radiology & Nuclear Medicine
Ophthalmology
Psychiatry
Source :
European Journal of Epidemiology, Eur. J. Epidemiol., European Journal of Epidemiology, Springer Verlag, 2019, 34 (2), pp.141-152. ⟨10.1007/s10654-018-00478-y⟩, European Journal of Epidemiology, 2019, 34 (2), pp.141-152. ⟨10.1007/s10654-018-00478-y⟩, European Journal of Epidemiology, 34(2), 141-152. Springer Netherlands
Publication Year :
2019

Abstract

International audience; To analyze the longitudinal relationships between vision loss and the risk of dementia in the first 2 years, from 2 to 4 years and beyond 4 years after inclusion and to determine the roles of depressive symptomatology and engagement in cognitively stimulating activities in these associations. This study is based on the Three-City (3C) study, a population-based cohort of 7736 initially dementia-free participants aged 65 years and over with 12 years of follow-up. Near visual impairment (VI) was measured and distance visual function (VF) loss was self-reported. Dementia was diagnosed and screened over the 12-year period. At baseline, 8.7% had mild near VI, 4.2% had moderate to severe near VI, and 5.3% had distance VF loss. Among the 882 dementia cases diagnosed over the 12-year follow-up period, 140 cases occurred in the first 2 years, 149 from 2 to 4 years and 593 beyond 4 years after inclusion. In Cox multivariate analysis, moderate to severe near VI was associated with an increased risk of dementia in the first 2 years (HR 2.0, 95% CI 1.2-3.3) and from 2 to 4 years (HR 1.8, 95% CI 1.1-3.1) but the association was not significant beyond 4 years after inclusion even if pointing in similar direction (HR 1.3, 95% CI 0.95-1.9). Mild near VI was associated with an increased risk of dementia only in the first 2 years (HR 1.6, 95% CI 1.1-2.5). Moreover, self-reported distance VF loss was associated with an increased risk beyond 4 years after inclusion (HR 1.5, 95% CI 1.1-2.0) but the association was no longer significant after taking into account baseline cognitive performances. Further adjustment for engagement in cognitively stimulating activities only slightly decreased these associations. However, there was an interaction between vision loss and depressive symptomatology, with vision loss associated with dementia only among participants with depressive symptomatology. These results suggest that poor vision, in particular near vision loss, may represent an indicator of dementia risk at short and middle-term, mostly in depressed elderly people.

Details

ISSN :
03932990 and 15737284
Volume :
34
Issue :
2
Database :
OpenAIRE
Journal :
European Journal of Epidemiology
Accession number :
edsair.doi.dedup.....bff564f03d371c7ea76cc8dc341a42f1
Full Text :
https://doi.org/10.1007/s10654-018-00478-y⟩